METASTATIC NON-SQUAMOUS NON SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NON-SQUAMOUS NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NON-SQUAMOUS NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NON-SQUAMOUS NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus therapy trial offers new hope for Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing a new two-step treatment for advanced non-small cell lung cancer that has started to grow again after initial therapy. One group receives an intravenous modified virus designed to attack cancer cells, followed by standard chemotherapy and immunotherapy. The …
Matched conditions: METASTATIC NON-SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New hope for lung cancer patients: experimental drug trial seeks to boost standard treatment
Disease control Recruiting nowThis trial is testing whether adding an experimental drug called visugromab to standard first-line treatment helps people with newly diagnosed, advanced non-squamous lung cancer. About 107 participants will be randomly assigned to receive either the new combination or the standar…
Matched conditions: METASTATIC NON-SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated Mar 23, 2026 15:28 UTC
-
New antibody joins fight against tough lung cancers
Disease control Recruiting nowThis study is testing whether adding a new antibody drug called visugromab to standard treatments helps control advanced non-small cell lung cancer that has worsened after initial therapy. It will compare different combinations of visugromab, an immunotherapy drug (nivolumab), an…
Matched conditions: METASTATIC NON-SQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated Feb 23, 2026 14:56 UTC